Gameto

Clinic Spotlight: Gameto is proud to partner with Concebir - Centro de fertilidad in Peru to offer our product, Fertilo, to patients seeking reproductive care. Under the leadership of Luis Guzmán, PhD and Dra. Pamela Villanueva Zú?iga at Pranor, the world’s first baby conceived using Fertilo was born last year – a significant milestone in reproductive medicine. If you are a patient in Peru interested in learning more about Fertilo and its benefits, reach out to Pranor directly to determine if you are a fit.

Clinic Spotlight: Gameto is excited to be partnered with Grupo Procrearte in Buenos Aires, the first clinic in Argentina to be offering Fertilo to patients. If you are a patient in Argentina interested in learning more about Fertilo and its benefits, reach out to Procrearte directly to determine if you are a fit. Gaston Rey Valzacchi

Today marks the first day of the Pacific Coast Reproductive Society's 2025 Annual Meeting in Indian Wells, CA, where experts in reproductive medicine gather to share the latest advancements in the field. Gameto's Chief Medical Officer, Dr. Gus Haddad, will be attending, engaging with leaders and innovators to discuss the future of fertility care. If you're attending, we’d love to connect—see you there! #reproductivehealth #womenshealth #PCRS2025

Gameto’s Phase 3 Clinical Trial study site is now live and in start-up phase with our investigator sites. The study is termed Fertilo in Vitro Research Study and Trial (FIRST), as it is the first ever Phase 3 trial in the United States using iPSC-derived cells. FIRST will be conducted at 15 sites across the United States in women aged 18 to 35 years old who meet the listed inclusion criteria. Stay tuned as we announce our study sites shortly! Link to our study site: https://lnkd.in/edhsxa7Y

Dr. Dina Radenkovic Turner, our CEO & Co-founder, spoke with Pharmaceutical Executive and shared key insights on how to bridge the gap in women’s health innovation and how we can better incentivize R&D in this critical space. In this interview, Dina highlights the challenges and opportunities in advancing women's health, from the need for better research models to the importance of policy reform and funding. Gameto’s work in iPSC-derived fertility treatments, including our lead product, Fertilo, now in Phase III clinical trials in the US, is a prime example of how cutting-edge science can drive real change in women's health. Watch the full Pharmaceutical Executive interview with Dina here: https://lnkd.in/eTpnywNe

?? International Women’s Day was a great way to start #SXSW! The focus on #WomensHealth has taken the stage. It was awesome to hear from Dr. Dina Radenkovic Turner of Gameto and Kim Smith, FACHE of Health Evolve, alongside an incredible lineup of leaders on the urgency and momentum driving change in women’s healthcare today. Thank you, Jennifer Kite-Powell, creator & host of the Tiny Little Victories Podcast, for amplifying these important conversations and sharing the impact of leaders like Kim who is working to transform women’s #healthcare. And because every great conversation deserves something sweet, shoutout to Sarah Hamouda for bringing her amazing FIX Dessert Chocolatier from #Dubai to SXSW! ??? #IWD #WomensHealth #SXSW #SpiteTracking #FemTech #Innovation

Reflecting on #InternationalWomensDay, the Mirvie team was moved by the energy, conversations, and commitment to #womenshealth at SXSW. From highlighting breakthroughs in the field to dynamic discussions on the need to pivot in this ever-changing landscape to achieve success, there was no better way to honor this day alongside visionaries like Dina Radenkovic Turner, Olivia Walton and Chelsea M.R. Hirschhorn and discuss how we keep up the momentum to fill the gaps in women’s health. #pregnancyhealth #maternalhealth

This International Women’s Day, Gameto hosted a panel at #SXSW to discuss the future of women’s health. We discussed biotech, consumer healthcare, investment, and advocacy and shared insights on how technology is reshaping care and why advancing innovative solutions in women’s health is more important than ever. The panelists explored the many benefits of working in women’s health, including the vast white space for novel treatments, diagnostics, and consumer products, along with the increasing financial power of women. At the same time, they addressed key challenges—such as the lack of dedicated women’s health divisions in pharma, gaps in basic education, censorship and the absence of strong IPO precedents. The conversation focused on actionable takeaways to drive progress and ensure women’s health gets the attention and investment it deserves. Thank you to our panelists and everyone who joined us. Let’s keep the momentum going! Dina Radenkovic Turner, Chelsea Hirschhorn, Maneesh Jain, Olivia Walton, Frida, Mirvie, Ingeborg Investments

This year, on International Women’s Day, join us at #SXSW for a panel discussion that brings together founders, investors and advocates who are making a change in the women’s health space. The panel will take place at the conference held in Austin, Texas on Saturday, March 8th from 2:30-3:30pm local time. We hope to see you there! Dina Radenkovic Turner, Chelsea M.R. Hirschhorn, Maneesh Jain, Olivia Sterns Walton, Frida, Mirvie, Ingeborg Investments https://lnkd.in/gTSsPRBn

Have you heard? The official #SXSW schedule has been announced! Gameto’s CEO & Co-founder, Dina Radenkovic Turner, will be speaking on a panel at this year’s conference. ‘Transforming Women’s Health: From Pain to Progress” features panelists who are transforming the women’s health field through groundbreaking technologies, innovative investments, and paradigm-shifting policies. Dina will be joined by Mirvie’s Maneesh Jain, Ingeborg Investments’ Olivia Sterns Walton, and Frida’s Chelsea M.R. Hirschhorn. We look forward to an exciting discussion between this dynamic group! More details here: https://lnkd.in/gTSsPRBn